Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient

Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Thoracic Oncology - Volume 10, Issue 6, June 2015, Pages e40-e43

Matthias MD, Sabine PhD, Marc MD, Jana PhD, Masyar MD, Sebastian MD, Laura MD, Anne M MD, Florian PhD, Frauke PhD, Carsten MD, Katharina PhD, Lukas C. MB, PhD, Martin L. MD, Roman K. MD, Reinhard MD, Jürgen MD,